Transcranial Magnetic Stimulation Device Cleared for Anxious Depression
The outpatient procedure provides noninvasive magnetic stimulation through a cushioned helmet to targeted areas of the brain.
Mood Disorders
Lyme Disease Tied to Higher Risk for Psychiatric Conditions, Suicide
Risk particularly heightened in the six months following diagnosis
Exposure to Prenatal Antipsychotics Seems Safe
No increased risk seen for ADHD, ASD, small for gestational age with prenatal antipsychotics exposure
MPR Weekly Dose Podcast Episode 88
The FDA authorizes a postexposure prophylaxis for COVID-19; A new treatment is okay’d for lupus; A higher dose naloxone nasal spray became available; The risk evaluation and mitigation program for Clozapine has had important changes, and finally, Istodax has had an indication withdrawn.
Study Shows Loneliness Tied to Use of High-Risk Medications
The study authors utilized the National Social Life, Health, and Aging Project leave-behind questionnaire to obtain data on a total of 6017 adults over 65 years of age.
Antidepressant Use May Aid Outcomes in Depression and Diabetes
Regular vs poor antidepressant use tied to lower risk for advanced diabetic complications, mortality in patients with depression and diabetes
Prescription Digital Therapeutic for Anxiety, Depression Treatment Launched
Ensemble is an AI-powered digital mental health coach app designed to address the symptoms of MDD or GAD.
Prescription Drug Dispensing to Children Down During Pandemic
Percentage changes were −51.3 and −17.4 percent for drug classes typically treating acute infections, chronic diseases
MPR Weekly Dose Podcast Episode 85
This week Pfizer recalled their smoking cessation therapy Chantix. A treatment for acute bacterial skin and skin structure infections becomes available. Aduhelm, the newly approved Alzheimer Disease treatment, has its label updated. A blood lead level test is recalled, and there’s updates to the cancer drug Keytruda.
Drug May Curb ‘Sluggish’ Thinking in Some Adults With ADHD
Lisdexamfetamine found to reduce symptoms of sluggish cognitive tempo in small group of adults with ADHD
